The evolving research landscape, with advances in the omics technologies, availability of large-scale patient cohorts, and forthcoming availability of novel drugs in primary biliary cholangitis (PBC), is creating a unique opportunity for developing a precision medicine (PM) program. PM has potential to change the paradigm of management. Diagnostic work-up of PBC patients may include information on genetic variants and molecular signature to define a particular subtype of disease and provide an estimate of treatment response and survival. To reach this point, specific interventions, such as sequencing more genomes, creating bigger biobanks, and linking biological information to health data, are needed.

Cristoferi, L., Nardi, A., Invernizzi, P., Mells, G., Carbone, M. (2018). Individualizing Care: Management Beyond Medical Therapy. CLINICS IN LIVER DISEASE, 22(3), 545-561 [10.1016/j.cld.2018.03.006].

Individualizing Care: Management Beyond Medical Therapy

Cristoferi, Laura;Invernizzi, Pietro;Carbone, Marco
2018

Abstract

The evolving research landscape, with advances in the omics technologies, availability of large-scale patient cohorts, and forthcoming availability of novel drugs in primary biliary cholangitis (PBC), is creating a unique opportunity for developing a precision medicine (PM) program. PM has potential to change the paradigm of management. Diagnostic work-up of PBC patients may include information on genetic variants and molecular signature to define a particular subtype of disease and provide an estimate of treatment response and survival. To reach this point, specific interventions, such as sequencing more genomes, creating bigger biobanks, and linking biological information to health data, are needed.
Articolo in rivista - Review Essay
Autoimmune liver disease; Individualized care; Novel therapies; Omics; Precision medicine; Primary biliary cholangitis; Risk-stratification; Hepatology
English
2018
22
3
545
561
none
Cristoferi, L., Nardi, A., Invernizzi, P., Mells, G., Carbone, M. (2018). Individualizing Care: Management Beyond Medical Therapy. CLINICS IN LIVER DISEASE, 22(3), 545-561 [10.1016/j.cld.2018.03.006].
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/10281/219171
Citazioni
  • Scopus 3
  • ???jsp.display-item.citation.isi??? 2
Social impact